A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
Screening/ Drug efficacy/ Sotorasib/ Adaura and morePor Plenary Session
…
continue reading
My UCSF lecture on driver mutation lung cancerPor Plenary Session
…
continue reading
We break down the best studies from ASCOPor Plenary Session
…
continue reading
1
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
1:54:09
1:54:09
Reproducir más Tarde
Reproducir más Tarde
Listas
Me gusta
Me gusta
1:54:09
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionPor Plenary Session
…
continue reading
What you need to know in advance of ASCOPor Plenary Session
…
continue reading
Should trials have carbon footprint as an endpoint?Por Plenary Session
…
continue reading
My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and morePor Plenary Session
…
continue reading
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearPor Plenary Session
…
continue reading
Patient advocates, Pharma funding, and is MRD a suitable endpointPor Plenary Session
…
continue reading
5 reasons that is a bad ideaPor Plenary Session
…
continue reading
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".Por Plenary Session
…
continue reading
They are shittyPor Plenary Session
…
continue reading
Another flawed study Keynote 564. Pembro in adjuvant RCCPor Plenary Session
…
continue reading
What happens when doctors run unethical studies?Por Plenary Session
…
continue reading
Does car T cause secondary AML?We discussPor Plenary Session
…
continue reading
We talk about 2023 cancer trialsPor Plenary Session
…
continue reading
Goodman and I discuss ash updates.My myeloma talkhttps://www.youtube.com/watch?v=jAz84yCnfjQPor Plenary Session
…
continue reading